Moreover, baseline gut microbiota enriched with Faecalibacterium and other Firmicutes was associated with beneficial clinical response to immune checkpoint inhibitor targeting cytotoxic T-lymphocyte-associated protein 4 (CTLA-4) (Ipilimumab) in melanoma patients [83]. Here, CTLA4 is linked to melanoma.